| Merck (Schweiz) AG - Ogsiveo 100 mg, Filmtabletten | | 70389 | | 01 | | Ogsiveo 100 mg | | Filmtabletten | | L01XX81 | | Nirogacestat | | 19.05.2026 | | |
| | Composition | | nirogacestatum 100 mg ut nirogacestatum dihydrobromidum 133.049 mg, cellulosum microcristallinum, lactosum monohydricum 115.65 mg, carboxymethylamylum natricum A corresp. natrium max. 1.1 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli mono/dicaprylocapras, poly(alcohol vinylicus), E 110 0.09 mg, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Nirogacestatum | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 110 | 0.09 mg | color. | | E 171 | | color. | | E 172 | | color. | | Glyceroli Mono/dicaprylocapras | | | | Lactose Monohydrate | 115.65 mg | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 56 | | | A | | Non |
|
|
